CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-06 | Saik Andrew Chief Financial Officer | Grant or award | +250,000 | 300,000 | ||
| 2020-05-06 | Saik Andrew Chief Financial Officer | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2020-05-06 | Harsch Mutya Chief Legal Officer and GC | Grant or award | +150,000 | 320,712 | ||
| 2020-05-06 | Harsch Mutya Chief Legal Officer and GC | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2020-05-06 | Domzalski David President and CEO | Grant or award | +680,000 | 1,247,213 | ||
| 2020-05-06 | Domzalski David President and CEO | Grant or award · Stock Options | +680,000 | 680,000 | ||
| 2020-04-06 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −908 | $1.40 | $1K | 203,967 |
| 2020-04-06 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −3,763 | $1.40 | $5K | 180,901 |
| 2020-04-06 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −4,474 | $1.40 | $6K | 170,712 |
| 2020-04-06 | Domzalski David President and CEO | Shares withheld for taxes | −11,772 | $1.40 | $16K | 567,213 |
| 2020-04-03 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +46,394 | 113,445 | ||
| 2020-04-03 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +91,430 | 204,875 | ||
| 2020-04-03 | Stuart Iain Chief Scientific Officer | Grant or award | +27,530 | 86,982 | ||
| 2020-04-03 | Stuart Iain Chief Scientific Officer | Grant or award | +97,682 | 184,664 | ||
| 2020-04-03 | Hirsch Stanley Director | Grant or award | +63,844 | 130,107 | ||
| 2020-04-03 | Hirsch Stanley Director | Grant or award | +220,496 | 328,609 | ||
| 2020-04-03 | Hirsch Stanley Director | Grant or award | +71,303 | 201,410 | ||
| 2020-04-03 | Harsch Mutya Chief Legal Officer and GC | Grant or award | +26,381 | 82,884 | ||
| 2020-04-03 | Harsch Mutya Chief Legal Officer and GC | Grant or award | +92,302 | 175,186 | ||
| 2020-04-03 | Domzalski David President and CEO | Grant or award | +141,901 | 329,397 |
Page 13 of 22 · 425 trades